Anixa Biosciences (ANIX) Stock Forecast, Price Target & Predictions

ANIX Stock Forecast

Anixa Biosciences stock forecast is as follows: an average price target of $3.50 (represents a 30.11% upside from ANIX’s last price of $2.69) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

ANIX Price Target

The average price target for Anixa Biosciences (ANIX) is $3.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $3.50 to $3.50. This represents a potential 30.11% upside from ANIX's last price of $2.69.

ANIX Analyst Ratings

Buy

According to 3 Wall Street analysts, Anixa Biosciences's rating consensus is 'Buy'. The analyst rating breakdown for ANIX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Anixa Biosciences Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Sep 17, 2024	Yi Chen	H.C. Wainwright	$3.50	$1.72	103.49%	30.11%
Dec 23, 2022	Matthew Barcus	Chardan Capital	$4.00	$1.91	109.42%	48.70%

The latest Anixa Biosciences stock forecast, released on Sep 17, 2024 by Yi Chen from H.C. Wainwright, set a price target of $3.50, which represents a 103.49% increase from the stock price at the time of the forecast ($1.72), and a 30.11% increase from ANIX last price ($2.69).

Anixa Biosciences Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$3.50
Last Closing Price	$2.69	$2.69	$2.69
Upside/Downside	-100.00%	-100.00%	30.11%

In the current month, the average price target of Anixa Biosciences stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Anixa Biosciences's last price of $2.69. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 17, 2024	H.C. Wainwright	Buy	Buy	Hold
Aug 07, 2024	EF Hutton		Buy	Initialise
Jun 10, 2024	H.C. Wainwright	Buy	Buy	Hold
Dec 23, 2022	Chardan Capital		Buy	Initialise

Anixa Biosciences's last stock rating was published by H.C. Wainwright on Sep 17, 2024. The company gave ANIX a "Buy" rating, the same as its previous rate.

Anixa Biosciences Financial Forecast

Anixa Biosciences Revenue Forecast

	Oct 28	Jul 28	May 28	Jan 28	Oct 27	Jul 27	May 27	Jan 27	Oct 26	Jul 26	May 26	Jan 26	Oct 25	Jul 25	May 25	Jan 25	Oct 24	Jul 24	May 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$605.68K
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$726.82K
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$484.54K
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Anixa Biosciences's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ANIX's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Anixa Biosciences EBITDA Forecast

	Oct 28	Jul 28	May 28	Jan 28	Oct 27	Jul 27	May 27	Jan 27	Oct 26	Jul 26	May 26	Jan 26	Oct 25	Jul 25	May 25	Jan 25	Oct 24	Jul 24	May 21
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-2.59M
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-2.07M
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-3.11M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict ANIX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Anixa Biosciences's previous annual EBITDA (undefined) of $NaN.

Anixa Biosciences Net Income Forecast

	Oct 28	Jul 28	May 28	Jan 28	Oct 27	Jul 27	May 27	Jan 27	Oct 26	Jul 26	May 26	Jan 26	Oct 25	Jul 25	May 25	Jan 25	Oct 24	Jul 24	May 21
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-2.16M	$-2.08M	$-1.93M	$-1.85M	$-2.06M	$-1.98M	$-1.83M	$-1.76M	$-1.96M	$-1.89M	$-1.75M	$-2.10M	$-3.09M	$-3.05M	$-2.81M	$-2.77M	$-2.72M	$-2.72M	$-2.61M
High Forecast	$-2.16M	$-2.08M	$-1.93M	$-1.85M	$-2.06M	$-1.98M	$-1.83M	$-1.76M	$-1.96M	$-1.89M	$-1.75M	$-2.10M	$-3.09M	$-3.05M	$-2.81M	$-2.77M	$-2.72M	$-2.72M	$-2.09M
Low Forecast	$-2.16M	$-2.08M	$-1.93M	$-1.85M	$-2.06M	$-1.98M	$-1.83M	$-1.76M	$-1.96M	$-1.89M	$-1.75M	$-2.10M	$-3.09M	$-3.05M	$-2.81M	$-2.77M	$-2.72M	$-2.72M	$-3.13M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Anixa Biosciences's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ANIX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Anixa Biosciences SG&A Forecast

	Oct 28	Jul 28	May 28	Jan 28	Oct 27	Jul 27	May 27	Jan 27	Oct 26	Jul 26	May 26	Jan 26	Oct 25	Jul 25	May 25	Jan 25	Oct 24	Jul 24	May 21
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.17M
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.80M
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$6.53M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Anixa Biosciences's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ANIX last annual SG&A of $NaN (undefined).

Anixa Biosciences EPS Forecast

	Oct 28	Jul 28	May 28	Jan 28	Oct 27	Jul 27	May 27	Jan 27	Oct 26	Jul 26	May 26	Jan 26	Oct 25	Jul 25	May 25	Jan 25	Oct 24	Jul 24	May 21
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-0.07	$-0.07	$-0.06	$-0.06	$-0.06	$-0.06	$-0.06	$-0.05	$-0.06	$-0.06	$-0.05	$-0.07	$-0.10	$-0.10	$-0.09	$-0.09	$-0.09	$-0.09	$-0.10
High Forecast	$-0.07	$-0.07	$-0.06	$-0.06	$-0.06	$-0.06	$-0.06	$-0.05	$-0.06	$-0.06	$-0.05	$-0.07	$-0.10	$-0.10	$-0.09	$-0.09	$-0.09	$-0.09	$-0.10
Low Forecast	$-0.07	$-0.07	$-0.06	$-0.06	$-0.06	$-0.06	$-0.06	$-0.05	$-0.06	$-0.06	$-0.05	$-0.07	$-0.10	$-0.10	$-0.09	$-0.09	$-0.09	$-0.09	$-0.10
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Anixa Biosciences's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ANIX previous annual EPS of $NaN (undefined).

Anixa Biosciences Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
INAB	IN8bio	$0.29	$14.00	4727.59%	Buy
MOLN	Molecular Partners	$5.25	$29.00	452.38%	Buy
AVTE	Aerovate Therapeutics	$2.56	$13.00	407.81%	Hold
ANVS	Annovis Bio	$5.11	$25.50	399.02%	Buy
ANEB	Anebulo Pharmaceuticals	$1.31	$6.00	358.02%	Buy
INMB	INmune Bio	$4.98	$22.00	341.77%	Buy
PYPD	PolyPid	$2.50	$10.00	300.00%	Buy
PMVP	PMV Pharmaceuticals	$1.52	$6.00	294.74%	Buy
ANTX	AN2 Therapeutics	$1.34	$5.00	273.13%	Buy
ACRV	Acrivon Therapeutics	$7.21	$22.50	212.07%	Buy
CUE	Cue Biopharma	$1.06	$3.00	183.02%	Buy
MLYS	Mineralys Therapeutics	$12.35	$30.00	142.91%	Buy
ADAG	Adagene	$2.10	$5.00	138.10%	Buy
IMNM	Immunome	$12.02	$23.00	91.35%	Buy
RZLT	Rezolute	$4.44	$6.67	50.23%	Buy
ACLX	Arcellx	$82.03	$111.60	36.05%	Buy
ANIX	Anixa Biosciences	$2.74	$3.50	27.74%	Buy

ANIX Forecast FAQ

Is Anixa Biosciences a good buy?

Yes, according to 3 Wall Street analysts, Anixa Biosciences (ANIX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of ANIX's total ratings.

What is ANIX's price target?

Anixa Biosciences (ANIX) average price target is $3.5 with a range of $3.5 to $3.5, implying a 30.11% from its last price of $2.69. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Anixa Biosciences stock go up soon?

According to Wall Street analysts' prediction for ANIX stock, the company can go up by 30.11% (from the last price of $2.69 to the average price target of $3.5), up by 30.11% based on the highest stock price target, and up by 30.11% based on the lowest stock price target.

Can Anixa Biosciences stock reach $4?

ANIX's average twelve months analyst stock price target of $3.5 does not support the claim that Anixa Biosciences can reach $4 in the near future.

What are Anixa Biosciences's analysts' financial forecasts?

Anixa Biosciences's analysts financial forecasts for the fiscal year (Oct 2027) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-7.632M (high $-7.632M, low $-7.632M), average SG&A $0 (high $0, low $0), and average EPS is $-0.238 (high $-0.238, low $-0.238). ANIX's analysts financial forecasts for the fiscal year (Oct 2028) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-8.02M (high $-8.02M, low $-8.02M), average SG&A $0 (high $0, low $0), and average EPS is $-0.25 (high $-0.25, low $-0.25).